Psoriasis. [N Engl J Med. 2009] - PubMed

loading

Genetics: Deep exploration. [Nature. 2012]
Genetics: Deep exploration.
Garber K. Nature. 2012 Dec 20; 492(7429):S56-7.
Review Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research. [Br J Dermatol. 2007]
Review Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research.
Guttman-Yassky E, Krueger JG. Br J Dermatol. 2007 Dec; 157(6):1103-15. Epub 2007 Aug 21.
Immunopathogenesis of psoriasis. [An Bras Dermatol. 2010]
Immunopathogenesis of psoriasis.
Sanchez AP. An Bras Dermatol. 2010 Sep-Oct; 85(5):747-9.
Review Psoriasis: dysregulation of innate immunity. [Br J Dermatol. 2005]
Review Psoriasis: dysregulation of innate immunity.
Bos JD, de Rie MA, Teunissen MB, Piskin G. Br J Dermatol. 2005 Jun; 152(6):1098-107.
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. [Nat Med. 2009]
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis.
Caruso R, Botti E, Sarra M, Esposito M, Stolfi C, Diluvio L, Giustizieri ML, Pacciani V, Mazzotta A, Campione E, et al. Nat Med. 2009 Sep; 15(9):1013-5. Epub 2009 Aug 16.

New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast. [Drug Des Devel Ther. 2013]
New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.
Palfreeman AC, McNamee KE, McCann FE. Drug Des Devel Ther. 2013; 7:201-10. Epub 2013 Mar 27.
Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and th17 T-helper cell subsets and is a direct stat target gene. [PLoS One. 2013]
Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and th17 T-helper cell subsets and is a direct stat target gene.
Adamson A, Ghoreschi K, Rittler M, Chen Q, Sun HW, Vahedi G, Kanno Y, Stetler-Stevenson WG, O'Shea JJ, Laurence A. PLoS One. 2013; 8(3):e59367. Epub 2013 Mar 26.
Janus kinase inhibitors in autoimmune diseases. [Ann Rheum Dis. 2013]
Janus kinase inhibitors in autoimmune diseases.
O'Shea JJ, Kontzias A, Yamaoka K, Tanaka Y, Laurence A. Ann Rheum Dis. 2013 Apr; 72 Suppl 2:ii111-5.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Gene (OMIM)
Gene records associated with Online Mendelian Inheritance in Man (OMIM) records that cite the current articles in their reference lists.
Nucleotide (Weighted)
Nucleotide records associated with the current articles through the Gene database. These are the related sequences on the Gene record that are added manually by NCBI.
OMIM (calculated)
Online Mendelian Inheritance in Man (OMIM) records that include the current articles as references in the light bulb links within or in the citations at the end of the OMIM record. The references available through the light bulb link are collected using the PubMed related articles algorithm to identify records with similar terminology to the OMIM record.
OMIM (cited)
Online Mendelian Inheritance in Man (OMIM) records that include the current articles as reference cited at the end of the OMIM record.
Protein (Weighted)
Protein records associated with the current articles through related Gene database records. These are the related sequences on the Gene record that are added manually by NCBI.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Psoriasis.
Psoriasis.
N Engl J Med. 2009 Jul 30 ;361(5):496-509. doi: 10.1056/NEJMra0804595.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed